TP53 and serous adenocarcinoma: In cases where molecular testing is not performed, p53 IHC may be useful for screening for p53-abn endometrial carcinoma in tumors with high-grade histology or endometrioid carcinoma with high nuclear grade or overlapping features with serous adenocarcinoma [28].